Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use-Reference-Cited by-同舟云学术

Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use

Published:2016-08-30 Issue:12 Volume:63 Page:2146-2153
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Green Nancy S.¹,Manwani Deepa²,Qureshi Mahvish¹,Ireland Karen²,Sinha Arpan²,Smaldone Arlene M.³⁴

Affiliation:

1. Division of Pediatric Hematology; Oncology and Stem Cell Transplantation; Department of Pediatrics; Columbia University Medical Center; New York New York

2. Division of Pediatric Hematology-Oncology; Department of Pediatrics; Albert Einstein Medical School and Montefiore Hospital; New York New York

3. School of Nursing; Columbia University Medical Center; New York New York

4. College of Dental Medicine; CUMC

Funder

National Institute of Nursing Research

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference42 articles.

1. Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia;Ware;Blood,2011

2. Hydroxyurea for sickle cell anemia: What have we learned and what questions still remain?;McGann;Curr Opin Hematol,2011

3. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease;Zimmerman;Blood,2004

4. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group;Kinney;Blood,1999

5. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study;Hankins;Blood,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease;Pediatric Blood & Cancer;2024-02-06

2. Ten‐year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program;European Journal of Haematology;2022-09-02

3. Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-Globin;Experimental Hematology;2022-08

5. Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective;Pharmaceuticals;2022-06-16